Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

The association between symptoms and microbiologically defined response to tuberculosis treatment.

Hales CM, Heilig CM, Chaisson R, Leung CC, Chang KC, Goldberg SV, Gordin F, Johnson JL, Muzanyi G, Saukkonen J, Vernon A, Villarino ME, Burman WJ.

Ann Am Thorac Soc. 2013 Feb;10(1):18-25. doi: 10.1513/AnnalsATS.201207-038OC.

2.

Clinical symptoms and microbiological outcomes in tuberculosis treatment trials.

Bark CM, Dietze R, Okwera A, Quelapio MI, Thiel BA, Johnson JL.

Tuberculosis (Edinb). 2011 Nov;91(6):601-4. doi: 10.1016/j.tube.2011.05.007. Epub 2011 Aug 2.

3.

Microbiological investigation for tuberculosis among HIV-infected children in Soweto, South Africa.

Fairlie L, Muchiri E, Beylis CN, Meyers T, Moultrie H.

Int J Tuberc Lung Dis. 2014 Jun;18(6):676-81. doi: 10.5588/ijtld.13.0839.

PMID:
24903938
4.

Symptom and chest radiographic screening for infectious tuberculosis prior to starting isoniazid preventive therapy: yield and proportion missed at screening.

Churchyard GJ, Fielding KL, Lewis JJ, Chihota VN, Hanifa Y, Grant AD.

AIDS. 2010 Nov;24 Suppl 5:S19-27. doi: 10.1097/01.aids.0000391018.72542.46.

PMID:
21079424
5.

Screening for pulmonary tuberculosis in HIV-infected individuals: AIDS Clinical Trials Group Protocol A5253.

Swindells S, Komarow L, Tripathy S, Cain KP, MacGregor RR, Achkar JM, Gupta A, Veloso VG, Asmelash A, Omoz-Oarhe AE, Gengiah S, Lalloo U, Allen R, Shiboski C, Andersen J, Qasba SS, Katzenstein DK; AIDS Clinical Trials Group 5253 Study Team.

Int J Tuberc Lung Dis. 2013 Apr;17(4):532-9. doi: 10.5588/ijtld.12.0737.

6.

Can tuberculosis case finding among health-care seeking adults be improved? Observations from Bissau.

Rudolf F, Haraldsdottir TL, Mendes MS, Wagner AJ, Gomes VF, Aaby P, Østergaard L, Eugen-Olsen J, Wejse C.

Int J Tuberc Lung Dis. 2014 Mar;18(3):277-85. doi: 10.5588/ijtld.13.0517.

PMID:
24670561
7.

Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.

Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N.

Cochrane Database Syst Rev. 2014 Jan 21;(1):CD009593. doi: 10.1002/14651858.CD009593.pub3. Review.

8.

Sublineages of Mycobacterium tuberculosis Beijing genotype strains and unfavorable outcomes of anti-tuberculosis treatment.

Hang NT, Maeda S, Keicho N, Thuong PH, Endo H.

Tuberculosis (Edinb). 2015 May;95(3):336-42. doi: 10.1016/j.tube.2015.02.040. Epub 2015 Feb 14.

PMID:
25732626
9.

Predicting results of mycobacterial culture on sputum smear reversion after anti-tuberculous treatment: a case control study.

Shu CC, Wang JT, Lee CH, Wang JY, Lee LN, Yu CJ.

BMC Infect Dis. 2010 Mar 6;10:48. doi: 10.1186/1471-2334-10-48.

10.

An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993.

Chum HJ, O'Brien RJ, Chonde TM, Graf P, Rieder HL.

AIDS. 1996 Mar;10(3):299-309.

PMID:
8882670
11.

Cough Aerosols of Mycobacterium tuberculosis in the Prediction of Incident Tuberculosis Disease in Household Contacts.

Jones-López EC, Acuña-Villaorduña C, Ssebidandi M, Gaeddert M, Kubiak RW, Ayakaka I, White LF, Joloba M, Okwera A, Fennelly KP.

Clin Infect Dis. 2016 Jul 1;63(1):10-20. doi: 10.1093/cid/ciw199. Epub 2016 Mar 29.

12.

Mycobacterium tuberculosis and human immunodeficiency virus coinfection in a tertiary care hospital in Midwestern Brazil.

Lins TB, Soares Ede M, dos Santos FM, Mandacaru PM, Pina T, de Araújo Filho JA.

Infez Med. 2012 Jun;20(2):108-16.

13.
14.

Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy.

Boulle A, Van Cutsem G, Cohen K, Hilderbrand K, Mathee S, Abrahams M, Goemaere E, Coetzee D, Maartens G.

JAMA. 2008 Aug 6;300(5):530-9. doi: 10.1001/jama.300.5.530.

PMID:
18677025
15.

Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis.

Khan FA, Minion J, Pai M, Royce S, Burman W, Harries AD, Menzies D.

Clin Infect Dis. 2010 May 1;50(9):1288-99. doi: 10.1086/651686. Review.

PMID:
20353364
16.

Clinical outcomes among persons with pulmonary tuberculosis caused by Mycobacterium tuberculosis isolates with phenotypic heterogeneity in results of drug-susceptibility tests.

Zetola NM, Modongo C, Moonan PK, Ncube R, Matlhagela K, Sepako E, Collman RG, Bisson GP.

J Infect Dis. 2014 Jun 1;209(11):1754-63. doi: 10.1093/infdis/jiu040. Epub 2014 Jan 16.

17.

A refined symptom-based approach to diagnose pulmonary tuberculosis in children.

Marais BJ, Gie RP, Hesseling AC, Schaaf HS, Lombard C, Enarson DA, Beyers N.

Pediatrics. 2006 Nov;118(5):e1350-9.

PMID:
17079536
18.

Urine lipoarabinomannan to monitor antituberculosis therapy response and predict mortality in an HIV-endemic region: a prospective cohort study.

Drain PK, Gounder L, Grobler A, Sahid F, Bassett IV, Moosa MY.

BMJ Open. 2015 Apr 15;5(4):e006833. doi: 10.1136/bmjopen-2014-006833.

19.

Risk Factors for Recurrent Tuberculosis among Successfully Treated Patients in Israel, 1999-2011.

Zhdanov V, Bilenko N, Mor Z.

Isr Med Assoc J. 2017 Apr;19(4):237-241.

20.

Oral antimicrobial rinse to reduce mycobacterial culture contamination among tuberculosis suspects in Uganda: a prospective study.

Kalema N, Boon SD, Cattamanchi A, Davis JL, Andama A, Katagira W, Everett C, Walter N, Byanyima P, Kaswabuli S, Worodria W, Huang L.

PLoS One. 2012;7(7):e38888. doi: 10.1371/journal.pone.0038888. Epub 2012 Jul 12.

Supplemental Content

Support Center